XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer

Introduction: Patient-derived xenografts (PDX) can be used to explore tumour pathophysiology and could be useful to better understand therapeutic response in breast cancer. PDX from mammary tumours are usually made from metastatic tumours. Thus, PDX from primary mammary tumours or after neoadjuvant...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:F1000Res
Hlavní autoři: Veyssière, Hugo, Passildas, Judith, Ginzac, Angeline, Lusho, Sejdi, Bidet, Yannick, Molnar, Ioana, Bernadach, Maureen, Cavaille, Mathias, Radosevic-Robin, Nina, Durando, Xavier
Médium: Artigo
Jazyk:Inglês
Vydáno: F1000 Research Limited 2021
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8258709/
https://ncbi.nlm.nih.gov/pubmed/34249349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.26873.3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky